a ­#Biobased­Future

The future is bio-based

Industrial biotechnology is our profession. Finding solutions for sustainable products and processes is our passion. Together with our customers, we are creating a #biobasedFuture.

A fermentation plant at Biocatalysts
© Biocatalysts

What we do

We enable industry partners to make products and processes more sustainable: with optimized enzymes, high-performance microorganisms and bioactive compounds.

Products and markets

How we do it

Our interdisciplinary, agile approach, scientific and application expertise, and a broad portfolio of biotech methods are key to our innovative solutions.


Why work with us?

As a solution provider for industry we bring customer projects to a fast and successful outcome.

Insight into a lab with a female lab technician, looking at something on the bench
© BRAIN Biotech

Genome editing tools to bring your projects to success rapidly and cost-efficiently

With our alternative genome editing tools, we bring your projects to success rapidly and cost-efficiently

We CRISPR for You

Customized Enzymes

We identify and develop optimized enzymes and biocatalysts that meet complex process and application requirements.


Bioprocess Development – Design For Manufacture

Our Bioprocess Development technology unit operates as a Contract Research Organization (CRO): it develops, optimizes and scales up microbial production processes on behalf of customers. To implement such processes successfully, our experts use the wide range of technical and support skills at their disposal.

Bioprocess Development

Microbial strain development

Based on our industry-leading collection of natural resources and data we identify, develop and optimize microbial production strains that meet our customers’ needs.

Microbial Strain Development

The BRAIN Biotech Group

The BRAIN Biotech Group provides first-class research and development work, specialized production expertise and access to attractive markets. All companies act as self-sufficient entities yet interconnect to synergize in R&D and production in the fields of biotechnology and natural product chemistry.

Latest press releases

Press release, 16 April 2024

BRAIN Biotech AG takes next step to optimize group structure

Read press release

Press release, 14 March 2024

Beverages made from vine leaves: Sustainable drinking pleasure based on agricultural side streams

Read press release

Press release, 12 March 2024

Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG

Read press release

News & Views

Interested in getting to know more about what drives the company and its people to find biotechnological answers to the questions of today’s industries? Check out our stories here:

13 March 2024
Sitting on a podium: Dr. Michael Majerus (Chairman of the Supervisory Board), Adriaan Moelker (CEO) and Michael Schneiders (CFO) during the Annual General Meeting.

Annual General Meeting 2024

Show article

7 March 2024
Large-Scale Freeze Drying facility at Biocatalysts Ltd

Biocatalysts Ltd expands its Manufacturing Capabilities with Large-Scale Freeze Drying

Show article

18 January 2024

Annual Report 2022/23

Show article

Since 2021 we have been committed to the UN Global Compact corporate responsibility initiative and its principles in the areas of human rights, labour, the environment and anti-corruption

ESG and Sustainability Report

Selected topic:

A collection of icons reffering to alternative proteins

Enabling #futurefood with precision fermentation

Nutrition in industrialized countries will move away from meat and dairy consumption towards alternative sources of protein and foods. These will rely on plants, microorganisms and cell cultures. Biotechnology will be the key enabler. This is where we come in.

Learn more

Share this page